Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
6.22
+0.17 (2.81%)
At close: Mar 9, 2026, 4:00 PM EDT
5.90
-0.32 (-5.14%)
After-hours: Mar 9, 2026, 6:16 PM EDT
Puma Biotechnology Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 228.37 | 230.47 | 235.64 | 228.03 | 253.16 | Upgrade
|
| Revenue Growth (YoY) | -0.91% | -2.19% | 3.34% | -9.92% | 12.46% | Upgrade
|
| Cost of Revenue | 58.16 | 64.4 | 62.68 | 55.09 | 63.7 | Upgrade
|
| Gross Profit | 170.21 | 166.06 | 172.96 | 172.94 | 189.45 | Upgrade
|
| Selling, General & Admin | 70.85 | 80.16 | 89.93 | 89.98 | 116.29 | Upgrade
|
| Research & Development | 62.07 | 54.94 | 50.38 | 52.24 | 71.87 | Upgrade
|
| Operating Expenses | 132.92 | 135.1 | 140.32 | 142.22 | 188.16 | Upgrade
|
| Operating Income | 37.3 | 30.97 | 32.64 | 30.72 | 1.29 | Upgrade
|
| Interest Expense | -6.62 | -12.45 | -13.33 | -11.59 | -12.81 | Upgrade
|
| Interest & Investment Income | 4.08 | 4.72 | 2.61 | 0.81 | 0.16 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.03 | 0.86 | 0.76 | -0.03 | 0.29 | Upgrade
|
| EBT Excluding Unusual Items | 35.78 | 24.1 | 22.67 | 19.91 | -11.07 | Upgrade
|
| Legal Settlements | - | - | - | -12.46 | -9.59 | Upgrade
|
| Other Unusual Items | - | - | - | - | -8.15 | Upgrade
|
| Pretax Income | 35.78 | 24.1 | 22.67 | 0.46 | -28.8 | Upgrade
|
| Income Tax Expense | 4.67 | -6.18 | 1.08 | 0.46 | 0.32 | Upgrade
|
| Net Income | 31.11 | 30.28 | 21.59 | 0 | -29.13 | Upgrade
|
| Net Income to Common | 31.11 | 30.28 | 21.59 | 0 | -29.13 | Upgrade
|
| Net Income Growth | 2.75% | 40.23% | 1079450.00% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 50 | 49 | 47 | 45 | 41 | Upgrade
|
| Shares Outstanding (Diluted) | 51 | 49 | 48 | 45 | 41 | Upgrade
|
| Shares Change (YoY) | 3.16% | 3.26% | 5.83% | 10.56% | 2.69% | Upgrade
|
| EPS (Basic) | 0.62 | 0.62 | 0.46 | 0.00 | -0.72 | Upgrade
|
| EPS (Diluted) | 0.61 | 0.62 | 0.45 | 0.00 | -0.72 | Upgrade
|
| EPS Growth | -1.61% | 37.78% | 1022625.00% | - | - | Upgrade
|
| Free Cash Flow | 41.73 | 38.86 | 26.87 | -15.83 | 20.65 | Upgrade
|
| Free Cash Flow Per Share | 0.82 | 0.79 | 0.56 | -0.35 | 0.51 | Upgrade
|
| Gross Margin | 74.53% | 72.06% | 73.40% | 75.84% | 74.84% | Upgrade
|
| Operating Margin | 16.33% | 13.44% | 13.85% | 13.47% | 0.51% | Upgrade
|
| Profit Margin | 13.62% | 13.14% | 9.16% | 0.00% | -11.51% | Upgrade
|
| Free Cash Flow Margin | 18.27% | 16.86% | 11.40% | -6.94% | 8.16% | Upgrade
|
| EBITDA | 47.44 | 41.09 | 42.86 | 40.56 | 12.6 | Upgrade
|
| EBITDA Margin | 20.77% | 17.83% | 18.19% | 17.79% | 4.98% | Upgrade
|
| D&A For EBITDA | 10.14 | 10.12 | 10.22 | 9.84 | 11.31 | Upgrade
|
| EBIT | 37.3 | 30.97 | 32.64 | 30.72 | 1.29 | Upgrade
|
| EBIT Margin | 16.33% | 13.44% | 13.85% | 13.47% | 0.51% | Upgrade
|
| Effective Tax Rate | 13.05% | - | 4.78% | 99.56% | - | Upgrade
|
| Revenue as Reported | 228.37 | 230.47 | 235.64 | 228.03 | 253.16 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.